The AIM-HI Accelerator Fund is fiercely dedicated to accelerating the commercialization of innovative lab breakthroughs into life-saving new therapies and technologies.
These words evoke a pathway. A pathway of progress that connects cancer research lab breakthroughs to game-changing novel technologies. Better cancer drugs, diagnostics and preventive tools for patients and their families and doctors. Tested and validated; making lives better.
I urge you to join AIM-HI’s exciting travel along this pathway on October 30, either in-person or virtually. Together with our strategic partner, the National Foundation for Cancer Research, we are proudly presenting:
This first-of-its-kind occasion consists of three programs:
- The Symposium for Translational Cancer Research, including sessions on the critically important topics of Immunotherapies, Personalized Treatments and Investment for Oncology Start-Ups
- Announcement of the winner of the AIM-HI Women’s Venture Competition
- Szent-Györgyi Prize for Progress in Cancer Research Awards Ceremony